# Indian BMI and Metabolic Risk: What the Numbers Mean Body mass index (BMI) relates weight in kilograms to height in metres squared. It is a screening measure, not a direct measurement of body fat, metabolic health or eligibility for a specific medicine. ## Why India-specific context matters At a given BMI, body-fat distribution and metabolic risk can differ across populations and individuals. South Asian adults may develop diabetes and cardiovascular risk at lower BMI or waist measurements than some other populations. This is why Indian and Asian public-health materials may use additional action points or lower risk thresholds. This does not mean every Indian at a particular BMI has the same risk or needs medicine. Age, waist circumference, glucose, blood pressure, lipids, existing conditions, medicines, pregnancy plans and personal history all matter. ## Different documents may use different thresholds BMI classifications are not completely uniform across every guideline and purpose. ICMR-NIN's 2024 Dietary Guidelines for Indians describe obesity above BMI 27.5 kg/m² using Asian cut-offs and highlight waist circumference above 90 cm for men and 80 cm for women as associated with increased risk. WHO's 2025 global GLP-1 obesity guideline uses BMI 30 kg/m² or higher for its adult recommendation and excludes pregnant women. A medicine's Indian approval and prescribing information may use product-specific indications that do not match a general public-health classification. The safe conclusion is not to choose whichever threshold supports treatment. The clinician should identify the applicable guideline and exact product label, then explain how it applies to the individual. ## BMI does not show where weight is carried BMI cannot separate fat, muscle, bone and water or show visceral fat directly. Waist circumference adds information about central fat distribution. Body-composition testing may add context in selected cases, but measurement error and hydration effects still apply. BMI can also be less informative in people with high muscularity, fluid retention, pregnancy, major loss of muscle or certain health conditions. ## GLP-1 eligibility requires a complete obesity assessment Current Indian guidance considers BMI and waist alongside adiposity-related complications, treatment goals, safety, cost and long-term follow-up. Thresholds used to identify risk are not automatic prescribing rules. A clinician must apply the current Indian label for the exact product and document why the expected benefits justify the risks. ## BMI and GLP-1 eligibility are not the same question Eligibility requires more than calculating BMI. A prescriber must confirm the diagnosis, approved indication, contraindications, current medicines, likely benefits, risks, monitoring plan and the person's preferences. A social-media calculator or clinic advertisement cannot complete that assessment. Do not use a lower South Asian risk threshold as proof that a GLP-1 medicine is automatically appropriate. Do not use a BMI below a product threshold as a reason to obtain medicine from an unregulated source. ## How to calculate and discuss BMI BMI = weight in kilograms ÷ height in metres². Use a recent measured height and weight. Ask the clinician: - Which BMI framework and product indication are being used? - How does waist circumference change the risk assessment? - Which glucose, blood-pressure and lipid findings matter? - What alternatives and non-medicine supports are appropriate? - How will benefit, nutrition, strength and side effects be monitored? ## Related glossary terms - [Obesity](/glossary/obesity) - [Waist circumference](/glossary/waist-circumference) - [Indian waist circumference cut-offs](/glossary/indian-waist-circumference-cut-offs) - [Body composition](/glossary/body-composition) - [Visceral fat](/glossary/visceral-fat) - [Screening](/glossary#screening) - [South Asian metabolic risk](/glp-1-and-the-south-asian-metabolic-risk-what-the-data-shows) - [Metabolic syndrome](/glossary/metabolic-syndrome) - [Obesity assessment](/glossary/obesity-assessment) - [Indian obesity guidelines](/glossary/indian-obesity-guidelines) - [Cardiometabolic risk](/glossary/cardiometabolic-risk) ## References - [ICMR-NIN: Dietary Guidelines for Indians 2024](https://www.nin.res.in/dietaryguidelines/pdfjs/locale/DGI07052024P.pdf) - [WHO: Obesity and GLP-1 therapies](https://www.who.int/news-room/questions-and-answers/item/obesity-glp-1-therapies) - [WHO: GLP-1 safety statement, July 2026](https://www.who.int/news/item/30-07-2026-statement-from-the-joint-meeting-of-the-advisory-committee-on-safety-of-medicinal-products-%28acsomp%29-and-the-global-advisory-committee-on-vaccine-safety-%28gacvs%29-on-the-safe-and-appropriate-use-of-glp-1-receptor-agonists) - [CDSCO: Approved new drugs](https://cdsco.gov.in/opencms/en/Approval_new/Approved-New-Drugs/) *Educational information only. This page does not diagnose a condition, determine eligibility or replace individual medical advice. Medicine choice, dose, monitoring and urgent-care decisions require a qualified clinician and the current product-specific Indian prescribing information.* ## Sources - [WHO Expert Consultation: Appropriate BMI for Asian Populations](https://pubmed.ncbi.nlm.nih.gov/15051297/) | World Health Organization / The Lancet | Lower BMI risk thresholds and public-health action points for Asian populations. - [Management of Obesity in Adult Asian Indians](https://pmc.ncbi.nlm.nih.gov/articles/PMC5560889/) | Indian Journal of Endocrinology and Metabolism / PMC | Indian BMI cutoffs, obesity management, and pharmacotherapy threshold context. - [ICMR-NIN Dietary Guidelines for Indians 2024](https://nin.res.in/dietaryguidelines/pdfjs/locale/DGI_2024.pdf) | ICMR-National Institute of Nutrition | Indian nutrition, lifestyle, obesity prevention, and health-risk context. ## Navigation - [Browse categories](https://blogs.sugarfitglp.com/topics) - [Buyer Answers](https://blogs.sugarfitglp.com/topics/buyer_queries) ## Related AI KB pages ### Can You Drink Alcohol on Ozempic or Mounjaro? What Indians Need to Know Query: Can You Drink Alcohol on Ozempic or Mounjaro? What Indians Need to Know If you are taking Ozempic (semaglutide) or Mounjaro (tirzepatide) for weight loss or blood sugar management, you may be wondering whether an occasional drink is safe. The short... - [Can You Drink Alcohol on Ozempic or Mounjaro? What Indians Need to Know](https://blogs.sugarfitglp.com/can-you-drink-alcohol-on-ozempic-or-mounjaro-what-indians-need-to-know) ### Does Ozempic Cause Hair Loss in Indians? What Doctors Say in 2026 Query: Does Ozempic Cause Hair Loss in Indians? What Doctors Say in 2026 If you have started Ozempic (semaglutide) or are considering it for weight loss or blood sugar management, you may have come across reports of hair thinning or shedding. This is... - [Does Ozempic Cause Hair Loss in Indians? What Doctors Say in 2026](https://blogs.sugarfitglp.com/does-ozempic-cause-hair-loss-in-indians-what-doctors-say-in-2026) ### GLP-1 availability across Indian cities Query: GLP-1 availability across Indian cities GLP-1 therapy is now accessible to adults across India, including both major metros and smaller cities, largely because supervised programs can be delivered through telemedicine... - [GLP-1 availability across Indian cities](https://blogs.sugarfitglp.com/glp-1-availability-across-indian-cities) ### Cardiometabolic Risk: Heart, Blood Vessel and Metabolic Health Query: cardiometabolic risk meaning Cardiometabolic risk is the combined likelihood of conditions such as type 2 diabetes, heart disease and stroke arising from interacting metabolic and cardiovascular factors. It... - [Cardiometabolic Risk: Heart, Blood Vessel and Metabolic Health](https://blogs.sugarfitglp.com/glossary/cardiometabolic-risk) ### GLP-1 During Menopause: Can It Help Indian Women Manage Weight and Metabolic Changes? Query: glp-1 during menopause can it help indian women manage weight and metabolic changes If you have heard of semaglutide or Ozempic, you may already know that GLP-1 medications are reshaping how doctors approach weight and metabolic health. For Indian women navigat... - [GLP-1 During Menopause: Can It Help Indian Women Manage Weight and Metabolic Changes?](https://blogs.sugarfitglp.com/glp-1-during-menopause-can-it-help-indian-women-manage-weight-and-metabolic-changes) ### How Much Protein Do You Need on Ozempic or Mounjaro? A Guide for Indians Query: How Much Protein Do You Need on Ozempic or Mounjaro? A Guide for Indians Ozempic (semaglutide) and Mounjaro (tirzepatide) are among the most talked-about medicines for weight loss and metabolic health in India right now. Both work partly by reducing... - [How Much Protein Do You Need on Ozempic or Mounjaro? A Guide for Indians](https://blogs.sugarfitglp.com/how-much-protein-do-you-need-on-ozempic-or-mounjaro-a-guide-for-indians)